Literature DB >> 10655401

Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.

A Marchese1, G Balistreri, E Tonoli, E A Debbia, G C Schito.   

Abstract

Of 179 methicillin-resistant Staphylococcus aureus strains isolated from 1997 to 1998, two strains (1.1%) gave subclones for which the vancomycin MICs were 8 mg/liter. Pulsed-field gel electrophoresis showed identical restriction patterns for both isolates, suggesting transfer of a single clone between two different patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655401      PMCID: PMC86227     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

Authors:  K Sieradzki; R B Roberts; S W Haber; A Tomasz
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

2.  Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-08-22       Impact factor: 17.586

3.  Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus.

Authors:  B Moreira; S Boyle-Vavra; B L deJonge; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.

Authors:  M C Ploy; C Grélaud; C Martin; L de Lumley; F Denis
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

5.  Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

Authors:  J Ariza; M Pujol; J Cabo; C Peña; N Fernández; J Liñares; J Ayats; F Gudiol
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

6.  Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.

Authors:  A Marchese; E A Debbia; D Bacca; G Balistreri; B Musolino; G C Schito
Journal:  Drugs       Date:  1997       Impact factor: 9.546

7.  Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Authors:  F C Tenover; M V Lancaster; B C Hill; C D Steward; S A Stocker; G A Hancock; C M O'Hara; S K McAllister; N C Clark; K Hiramatsu
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.

Authors:  G W Kaatz; S M Seo; N J Dorman; S A Lerner
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

9.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group.

Authors:  R B Roberts; A de Lencastre; W Eisner; E P Severina; B Shopsin; B N Kreiswirth; A Tomasz
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  In vitro morphogenesis of chick embryo hypertrophic cartilage.

Authors:  C Tacchetti; R Quarto; L Nitsch; D J Hartmann; R Cancedda
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

View more
  33 in total

Review 1.  Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Authors:  Catherine Liu; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in north India.

Authors:  Tuhina Banerjee; Shampa Anupurba
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

Review 3.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  VISA, hetero-VISA and VRSA: the end of the vancomycin era?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-09

5.  Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant.

Authors:  Hitoshi Komatsuzawa; Kouji Ohta; Sakuo Yamada; Kerstin Ehlert; Harald Labischinski; Junko Kajimura; Tamaki Fujiwara; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 6.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

7.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.

Authors:  Sandra M Tallent; Tammy Bischoff; Michael Climo; Belinda Ostrowsky; Richard P Wenzel; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

9.  Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.

Authors:  Poonam Sood Loomba; Juhi Taneja; Bibhabati Mishra
Journal:  J Glob Infect Dis       Date:  2010-09

10.  The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand.

Authors:  Aroonlug Lulitanond; Chulapan Engchanil; Prajuab Chaimanee; Malai Vorachit; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.